On October 6, U.S. spot Bitcoin ETFs attracted $118.8 million in net inflows, driven mainly by IBIT which contributed $122 million, making it the largest positive inflow among Bitcoin ETFs. In contrast, Ethereum ETFs experienced $201.9 million in net outflows, continuing a six-session streak of withdrawals, with ETHA accounting for $202 million of the outflows. Despite mixed flows across individual Bitcoin funds, the overall Bitcoin ETF inflows remained positive. This highlights a clear divergence in investor demand between Bitcoin and Ethereum exchange-traded products on that day.
Bitcoin ETFs inflows and Ethereum ETFs outflows provide context for cryptocurrency trends. For readers following crypto markets, here is Pluang's market snapshot as of Oct 07, 2026 11:02 WIB: out of 50 major cryptocurrencies priced on Pluang, 4 rose and 45 fell today. Notable movers include MANA at Rp1.747 with a 1-day change of -6.23%, ALGO at Rp2.145 down 6.21%, and AXS at Rp21.661 down 6.15%.
The Reserve Bank of India raised its key policy rate by 25 basis points to 5.5%, marking the first increase since 2023. This move aims to curb rising inflation, which has been increasing for 10 consecutive months and currently stands above the RBI's ...
Temasek, Singapore's state-owned investment firm, sees the biggest market risk as a potential reversal in the artificial intelligence (AI) trade, which currently supports U.S. stock highs despite rising Treasury yields. Factors like tighter regulatio...
U.S. spot Bitcoin exchange-traded funds (ETFs) recorded net inflows of $118.8 million on October 6, reversing a prior session's outflow. Over five days, total inflows reached $172.9 million, with BlackRock's iShares Bitcoin Trust leading at $122 mill...
Abstract, an Ethereum layer-2 blockchain focused on consumer applications, will shut down on December 15 after its parent company Igloo lost tens of millions of dollars funding it. Despite processing over 325 million transactions and hosting $6 billi...
Palindrome Pharma, a new Canadian pharmaceutical company, has launched with a focus on biosimilar medicines to improve access to biologic therapies and support a sustainable healthcare system. The company aims to build a diverse portfolio through par...
